Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer

NCT03016741 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03016741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 31, 2017
Completion date
August 31, 2029
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostatic cancer, hormone-refractory prostate cancer, metastatic prostate carcinoma, recurrent prostate carcinoma, stage iv prostate cancer